169 related articles for article (PubMed ID: 15727105)
21. [Acyclovir freely obtainable].
Lekkerkerker JF; Broekmans AW
Ned Tijdschr Geneeskd; 1996 Sep; 140(36):1832. PubMed ID: 8927151
[No Abstract] [Full Text] [Related]
22. A review of antiviral therapy for herpes labialis.
Vander Straten M; Carrasco D; Lee P; Tyring SK
Arch Dermatol; 2001 Sep; 137(9):1232-5. PubMed ID: 11559222
[No Abstract] [Full Text] [Related]
23. Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: a randomized, double-blind, placebo-controlled, patient-initiated clinical trial.
Hull CM; Harmenberg J; Arlander E; Aoki F; Bring J; Darpö B; Levin MJ; Tyring S; Spruance SL;
J Am Acad Dermatol; 2011 Apr; 64(4):696.e1-11. PubMed ID: 20851499
[TBL] [Abstract][Full Text] [Related]
24. Evidence for efficacy of topical acyclovir in recurrent herpes labialis is weak.
Worrall G
BMJ; 1996 Jul; 313(7048):46. PubMed ID: 8664786
[No Abstract] [Full Text] [Related]
25. Efficacy of acyclovir in the treatment of recurring herpes labialis, genitalis and acute herpes zoster.
Peralta S; Ribisi La Spina AM; Pirrotta P; Collura D; Formica P; Tinnirello D; Citarrella P; Mansueto S
J Chemother; 1989 Jul; 1(4 Suppl):1117-8. PubMed ID: 16312797
[No Abstract] [Full Text] [Related]
26. Protocol for a randomised controlled trial of 90% kanuka honey versus 5% aciclovir for the treatment of herpes simplex labialis in the community setting.
Semprini A; Singer J; Shortt N; Braithwaite I; Beasley R;
BMJ Open; 2017 Aug; 7(8):e017766. PubMed ID: 28775197
[TBL] [Abstract][Full Text] [Related]
27. Recent approval of Xerese in Canada: 5% acyclovir and 1% hydrocortisone topical cream in the treatment of herpes labialis.
Nguyen HP; Stiegel KR; Downing C; Stiegel KR
Skin Therapy Lett; 2014; 19(3):5-8. PubMed ID: 25188362
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of Topical 5% Acyclovir-1% Hydrocortisone Cream (ME-609) for Treatment of Herpes Labialis: a systematic review.
Rosa MI; Souza SL; Farias BF; Pires PD; Dondossola ER; dos Reis ME
An Acad Bras Cienc; 2015 Aug; 87(2 Suppl):1415-20. PubMed ID: 26247156
[TBL] [Abstract][Full Text] [Related]
29. Penciclovir: new preparation. Slightly effective.
Prescrire Int; 1999 Dec; 8(44):178. PubMed ID: 11503816
[TBL] [Abstract][Full Text] [Related]
30. Docosanol: new drug. Herpes labialis: barely more effective than an excipient.
Prescrire Int; 2009 Jun; 18(101):106-7. PubMed ID: 19637417
[TBL] [Abstract][Full Text] [Related]
31. Treatment of herpes labialis.
Fiddian AP; Yeo JM; Clark AE
J Infect; 1983 May; 6(1 Suppl):41-7. PubMed ID: 6350474
[TBL] [Abstract][Full Text] [Related]
32. Topical 5 percent acyclovir in polyethylene glycol for herpes simplex labialis. Antiviral effect without clinical benefit.
Spruance SL; Crumpacker CS
Am J Med; 1982 Jul; 73(1A):315-9. PubMed ID: 6285721
[TBL] [Abstract][Full Text] [Related]
33. Successful Therapy of Severe Oro-Labial Herpes Simplex With Muco-Adhesive Acyclovir.
Rosen T
J Drugs Dermatol; 2018 Apr; 17(4):479-480. PubMed ID: 29601626
[TBL] [Abstract][Full Text] [Related]
34. Recommendations for short-course therapies in herpes genitalis and herpes labialis.
Corey L; Stanberry L
Herpes; 2007 Jun; 14 Suppl 1():4A. PubMed ID: 17877885
[No Abstract] [Full Text] [Related]
35. An update on short-course intermittent and prevention therapies for herpes labialis.
Gilbert S; Corey L; Cunningham A; Malkin JE; Stanberry L; Whitley R; Spruance S
Herpes; 2007 Jun; 14 Suppl 1():13A-18A. PubMed ID: 17877887
[TBL] [Abstract][Full Text] [Related]
36. Fixed drug eruption due to acyclovir.
Montoro J; Basomba A
Contact Dermatitis; 1997 Apr; 36(4):225. PubMed ID: 9165208
[No Abstract] [Full Text] [Related]
37. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial.
Hull C; McKeough M; Sebastian K; Kriesel J; Spruance S
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):263-7. PubMed ID: 19143902
[TBL] [Abstract][Full Text] [Related]
38. Herpes virus-associated erythema multiforme following valacyclovir and systemic corticosteroid treatment.
Inoue K; Kano Y; Kagawa H; Hirahara K; Shiohara T
Eur J Dermatol; 2009; 19(4):386-7. PubMed ID: 19482587
[No Abstract] [Full Text] [Related]
39. Therapeutic options for herpes labialis, II: Topical agents.
Elish D; Singh F; Weinberg JM
Cutis; 2004 Jul; 74(1):35-40. PubMed ID: 15293698
[No Abstract] [Full Text] [Related]
40. Treatment of herpes simplex labialis.
Spruance SL; Kriesel JD
Herpes; 2002 Dec; 9(3):64-9. PubMed ID: 12470603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
